TRCT
TMO icon

Tower Research Capital (TRC)’s Thermo Fisher Scientific TMO Stock Holding History

Tower Research Capital (TRC)’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.32M Sell
6,754
-2,670
-28% -$1.45M 0.09% 233
2025
Q4 		$5.46M Buy
9,424
+3,091
+49% +$1.75M 0.13% 132
2025
Q3 		$3.07M Sell
6,333
-14,131
-69% -$6.58M 0.08% 205
2025
Q2 		$8.3M Sell
20,464
-1,362
-6% -$569K 0.22% 74
2025
Q1 		$10.8M Buy
21,826
+496
+2% +$269K 0.32% 42
2024
Q4 		$11.1M Buy
21,330
+8,946
+72% +$4.92M 0.22% 72
2024
Q3 		$7.66M Sell
12,384
-10,756
-46% -$6.37M 0.2% 65
2024
Q2 		$12.8M Buy
23,140
+13,251
+134% +$7.59M 0.22% 65
2024
Q1 		$5.75M Sell
9,889
-45,740
-82% -$25.7M 0.14% 110
2023
Q4 		$29.5M Buy
55,629
+40,207
+261% +$19.5M 0.36% 45
2023
Q3 		$7.81M Buy
15,422
+9,098
+144% +$4.85M 0.24% 63
2023
Q2 		$3.3M Sell
6,324
-645
-9% -$348K 0.11% 124
2023
Q1 		$4.02M Buy
6,969
+748
+12% +$422K 0.13% 101
2022
Q4 		$3.43M Sell
6,221
-31,219
-83% -$16.5M 0.14% 96
2022
Q3 		$19M Buy
37,440
+22,220
+146% +$12.4M 0.31% 54
2022
Q2 		$8.27M Sell
15,220
-37,180
-71% -$20.5M 0.19% 89
2022
Q1 		$30.9M Buy
52,400
+22,367
+74% +$12.8M 0.3% 60
2021
Q4 		$20M Buy
30,033
+23,093
+333% +$14.4M 0.35% 44
2021
Q3 		$3.96M Sell
6,940
-354
-5% -$194K 0.1% 129
2021
Q2 		$3.68M Sell
7,294
-30,722
-81% -$14.5M 0.1% 149
2021
Q1 		$17.4M Buy
38,016
+27,164
+250% +$13M 0.29% 61
2020
Q4 		$5.05M Buy
10,852
+2,693
+33% +$1.26M 0.15% 66
2020
Q3 		$3.6M Buy
8,159
+152
+2% +$62.8K 0.04% 139
2020
Q2 		$2.9M Buy
8,007
+4,242
+113% +$1.42M 0.12% 133
2020
Q1 		$1.07M Buy
3,765
+3,529
+1,495% +$1.11M 0.07% 216
2019
Q4 		$77K Sell
236
-8,000
-97% -$2.43M 0.01% 1099
2019
Q3 		$2.4M Buy
8,236
+8,215
+39,119% +$2.35M 0.16% 97
2019
Q2 		$6K Sell
21
-5,664
-100% -$1.56M ﹤0.01% 2875
2019
Q1 		$1.56M Sell
5,685
-4,964
-47% -$1.24M 0.09% 164
2018
Q4 		$2.38M Buy
10,649
+10,488
+6,514% +$2.46M 0.17% 124
2018
Q3 		$39K Sell
161
-8,789
-98% -$2.02M ﹤0.01% 1926
2018
Q2 		$1.85M Buy
+8,950
New +$1.9M 0.1% 182
2018
Q1 		– Sell
-2,405
Closed -$457K – 3819
2017
Q4 		$457K Buy
2,405
+1,758
+272% +$337K 0.06% 316
2017
Q3 		$122K Buy
647
+141
+28% +$25.5K 0.01% 1169
2017
Q2 		$88K Sell
506
-483
-49% -$81.1K 0.01% 546
2017
Q1 		$152K Sell
989
-9,019
-90% -$1.38M 0.02% 352
2016
Q4 		$1.41M Buy
10,008
+9,577
+2,222% +$1.41M 0.15% 149
2016
Q3 		$69K Sell
431
-3,289
-88% -$507K 0.01% 977
2016
Q2 		$549K Buy
3,720
+3,429
+1,178% +$506K 0.05% 249
2016
Q1 		$41K Buy
+291
New +$39K 0.01% 890
2015
Q2 		– Sell
-1,470
Closed -$197K – 5016
2015
Q1 		$197K Sell
1,470
-385
-21% -$49.6K 0.02% 420
2014
Q4 		$232K Sell
1,855
-8,942
-83% -$1.09M 0.02% 265
2014
Q3 		$1.31M Buy
10,797
+10,528
+3,914% +$1.28M 0.15% 129
2014
Q2 		$32K Sell
269
-5,094
-95% -$600K ﹤0.01% 1562
2014
Q1 		$645K Buy
5,363
+5,001
+1,381% +$595K 0.08% 177
2013
Q4 		$40K Sell
362
-11,465
-97% -$1.14M 0.01% 1587
2013
Q3 		$1.09M Buy
11,827
+10,987
+1,308% +$994K 0.12% 161
2013
Q2 		$71K Buy
+840
New +$69.9K 0.01% 689

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Tower Research Capital (TRC)'s TMO Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Thermo Fisher Scientific (TMO) stake by 28% in Q1 2026, selling an estimated $1.45M and leaving 6,754 shares worth $3.32M. The position accounts for 0.09% of the portfolio, ranked #233.

Tower Research Capital (TRC) first reported a position in TMO in Q2 2013 and has held it in 48 quarters since. The position peaked at $30.9M in Q1 2022. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Tower Research Capital (TRC) held 6,754 shares of Thermo Fisher Scientific worth $3.32M as of Q1 2026.
  • Tower Research Capital (TRC) sold 2,670 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.45M.
  • Thermo Fisher Scientific made up 0.09% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #233 holding.
  • Tower Research Capital (TRC) first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 48 quarters since.
  • Tower Research Capital (TRC)'s Thermo Fisher Scientific position peaked at $30.9M in Q1 2022.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.